<!DOCTYPE html>
<html>
<head>
	<meta charset="UTF-8">
	<script type="text/javascript">
	var methode = {};
	window.globe = window.globe || {};
	globe.version = '18279I1728';
</script>
<!-- /business auto:  -->
	<title>ImmunoGen&rsquo;s innovative &ldquo;payload platform&rdquo; powers potent Kadcyla breast cancer therapy - The Boston Globe</title>
<meta name="eomportal-instanceid" content="219"/>
<meta name="eomportal-id" content="1455023"/>
<meta name="eomportal-loid" content="3.2.4154197919"/>
<meta name="eomportal-uuid" content="e3c43f10-ef6a-11e3-8a49-f20cb1b355b9"/>
<meta name="eomportal-lastUpdate" content="Tue Oct 10 02:18:29 EDT 2017"/>
<style>
html{font-size:100%;line-height:1.625em}body.type-internal div#contain{margin:0}footer.bg-footer{display:none}body{padding-bottom:0}#contain{width:100%;margin-bottom:0}#contain #main{margin:0}#contain .mod.live-update{display:none}.article{width:100%;float:none;margin:0;padding-top:0}.article .article-body{padding-bottom:2em}.article .article-body .skip-nav{display:none}.article .article-body .ad.aside{display:none}.article .lead-figure.full{display:none}.saved-panel{display:none}#masthead,.header,.byline,.primary-tools,.section-nav,.cats-first,.in-section{display:none}header.article-nav{box-sizing:border-box;-moz-box-sizing:border-box;width:100%;margin:0}header.article-nav .bostonGlobeLogo{margin-top:2em;text-align:center}header.article-nav .bostonGlobeLogo .bg-logo img{max-width:173px}header.article-nav .gameChangersLogo{text-align:center;margin-bottom:2em}header.article-nav .gameChangersLogo .gc-logo img{width:100%;max-width:300px}header.article-nav *{box-sizing:border-box;-moz-box-sizing:border-box}header.article-nav .topRow{height:100%;overflow:hidden;padding:.5em;border-bottom:1px solid #ccc}header.article-nav .topRow .leftNav{width:50%;float:left}header.article-nav .topRow .leftNav .categoryNav{font-family:Helvetica,Arial,sans-serif;width:171px;border:1px solid #ccc;z-index:999}header.article-nav .topRow .leftNav .categoryNav .categoryButton{background:#fff;font-weight:700;text-transform:uppercase;font-size:.8em}header.article-nav .topRow .leftNav .categoryNav .categoryButton a{display:block;color:#666;text-decoration:none;padding:.75em 0}header.article-nav .topRow .leftNav .categoryNav .categoryButton a .plus{background:#666;color:#fff;padding:1em}header.article-nav .topRow .leftNav .categoryNav ul{position:absolute;border:1px solid #ccc;font-weight:400;border-top:none;width:170px}header.article-nav .topRow .leftNav .categoryNav ul li{background:#fff;color:#444;font-size:.8em;border-top:1px solid #ccc}header.article-nav .topRow .leftNav .categoryNav ul li a{padding:.75em .5em;display:block;text-decoration:none}header.article-nav .topRow .leftNav .categoryNav ul li:hover{background:#eee}header.article-nav .topRow .leftNav .categoryNav ul.hide{display:none}header.article-nav .topRow .leftNav .categoryNav .upTopCategory{position:absolute;width:100%;max-width:720px;background:#fff;border:1px solid #ccc;border-top:none;margin-top:.75em;left:0;padding:.5em;box-shadow:2px 1px 2px #ccc}header.article-nav .topRow .leftNav .categoryNav .upTopCategory .close{text-align:right}header.article-nav .topRow .leftNav .categoryNav .upTopCategory .close a{text-decoration:none;font-weight:700;text-transform:uppercase;font-size:.9em}header.article-nav .topRow .leftNav .categoryNav .upTopCategory .categoryLabel{font-weight:700;font-size:.9em}header.article-nav .topRow .leftNav .categoryNav .upTopCategory.hide{display:none}header.article-nav .topRow .rightNav{width:50%;text-align:right;float:left}header.article-nav .topRow .rightNav .globe-account{font-size:13px;font-family:Helvetica,Arial,sans-serif;text-transform:uppercase}header.article-nav .topRow .rightNav .globe-account a{line-height:44px;vertical-align:-webkit-baseline-middle;vertical-align:-moz-baseline-middle;vertical-align:baseline-middle;margin-left:.5em;color:#aaa;text-decoration:none}header.article-nav .topRow .rightNav .globe-account a:hover{color:#666}header.article-nav .topRow .stories{height:100%;overflow:hidden}header.article-nav .topRow .stories .story{box-sizing:border-box;-moz-box-sizing:border-box;text-align:left;width:50%;float:left;margin:.5em 0;height:80px;line-height:1.4}header.article-nav .topRow .stories .story a{height:100%;overflow:hidden;display:block;font-family:Helvetica,Arial,sans-serif;text-decoration:none;font-weight:400;padding-right:1.5em;color:#666;font-size:.9em}header.article-nav .topRow .stories .story img{max-height:80px;width:30%;display:block;float:left}header.article-nav .topRow .stories .story span{padding:0 .5em;display:block;width:70%;float:left}header.article-nav .articleInfo{text-align:center}header.article-nav .articleInfo .newHeadline{font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;font-size:2em;line-height:1.2;padding:0 .5em}header.article-nav .articleInfo .newByline{margin-bottom:1em}header.article-nav .articleInfo .newByline a{font-size:.8em;font-weight:700;text-decoration:none}header.article-nav .articleInfo .newByline cite{font-style:none}header.article-nav .articleInfo .figcaption{margin:0 auto;max-width:960px}header.article-nav .articleInfo .figcaption p{max-width:100%;text-align:left}header.article-nav .articleInfo .figcaption p.credit{text-align:right}header.article-nav .rightNav .commentSection img{max-width:16px}@media only screen and (max-width:480px){header.article-nav .articleInfo .newHeadline{font-size:1.4em}header.article-nav .gameChangersLogo{max-width:240px;margin:0 auto;margin-bottom:2em}header.article-nav .topRow .leftNav .categoryNav{display:none}header.article-nav .topRow .rightNav{width:100%}header.article-nav .topRow .rightNav .globe-account a{line-height:37px}}a.global-bar{display:none}.article-body *,.article-body *:before,.article-body *:after,header{-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box}.article-body{margin:0}.article-body .lead{position:relative}.article-body .lead img{width:100%}.article-body .lead .headerContainer{position:absolute;top:0;left:0;margin-left:33%;margin-top:11%;color:#fff;text-align:left;opacity:.9;text-shadow:0 2px 0 rgba(0,0,0,.3)}.article-body .lead .headerContainer .title{line-height:1.1;font-size:4.6em;font-family:"Miller Headline Roman","Times New Roman",Times,Georgia,serif;font-weight:400;margin-bottom:.4em;margin-right:2%}.article-body .lead .headerContainer .author a{color:#fff;font-size:1.3em;font-family:Georgia,"Times New Roman",Times,serif;font-weight:400;margin:0}.article-body .lead .headerContainer .author a span{text-transform:uppercase;font-size:.8em}.article-body p{max-width:720px;width:100%;margin:0 auto 1.125em auto}.article-body p:nth-child(3)::first-letter{font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;float:left;display:block;font-size:5em;color:#000;padding:0;margin:0;margin-right:.1em;line-height:1}.article-body p span.linebreak{display:block;height:1px;background:#ccc;margin:2.5em 0}.article-body p span.timeStamp{display:block;padding-top:2em;color:#aaa;font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;font-weight:300;font-size:.8em;text-transform:uppercase}.article-body p span.attributionBox{font-style:italic}.article-body p span.uppercase{text-transform:uppercase}.article-body .tease a{color:#000}.article-body .tease:visited{color:#000}.article-body .tease:hover{color:#96101E}.article-body .wide{max-width:720px;margin:0 auto;text-align:center}.article-body .wide .figcaption p{text-align:left}.article-body .wide .figcaption p.credit{text-align:right}.article-body .figure{margin-right:1em;max-width:320px}.article-body .columnWidth{width:100%;padding:0 1em}.article-body .centerText{text-align:center}.article-body em:last-child{display:block;max-width:720px;margin:0 auto;padding:0 .5em}.sourceCredits{text-align:right;max-width:720px;padding:1em .5em;font-size:.75em;font-weight:700;margin:0 auto}.sourceCredits .credits{font-weight:400;color:#aaa;text-align:right;text-transform:uppercase;font-size:.8em;letter-spacing:.05em}.sourceCredits .source{text-align:left}@media only screen and (max-width:730px){.article-body p{padding:0 1em}}#gf-special-graphic{max-width:960px;width:100%;margin:0 auto;padding-bottom:2em}#gf-special-graphic .sharing,#gf-special-graphic .social{font-family:Helvetica,Arial,sans-serif;text-transform:uppercase;color:#999;font-weight:400;font-size:.9em;text-align:center;margin:.5em 0}#gf-special-graphic .sharing a,#gf-special-graphic .social a{text-decoration:none}#gf-special-graphic .sharing img,#gf-special-graphic .social img{margin:.5em;max-height:32px}#gf-special-graphic .moreStories{margin-top:2em;font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;text-align:center;font-weight:700;padding:0 .5em}#gf-special-graphic .moreStories .categories{max-width:720px;margin:0 auto}#gf-special-graphic .moreStories .categories .label{font-family:Helvetica,Arial,sans-serif;border:1px solid #ccc;text-transform:uppercase;font-size:.8em;color:#666;font-weight:700;text-align:left;display:block;text-decoration:none;margin:.5em 0;padding:.75em 0}#gf-special-graphic .moreStories .categories .label:before{content:'+';margin-right:.25em;background:#666;color:#fff;padding:1em}#gf-special-graphic .moreStories .categories .label.hide:before{content:'-'}#gf-special-graphic .moreStories .stories{height:100%;overflow:hidden}#gf-special-graphic .moreStories .stories .story{box-sizing:border-box;-moz-box-sizing:border-box;text-align:left;width:50%;float:left;margin:.5em 0;height:80px;line-height:1.2}#gf-special-graphic .moreStories .stories .story a{height:100%;overflow:hidden;display:block;font-family:Helvetica,Arial,sans-serif;text-decoration:none;font-weight:400;padding-right:1.5em;color:#666;font-size:.9em}#gf-special-graphic .moreStories .stories .story img{max-height:80px;width:30%;display:block;float:left}#gf-special-graphic .moreStories .stories .story span{padding:0 .5em;display:block;width:70%;float:left}#gf-special-graphic .moreStories .stories.hide{display:none}.BrightcoveExperience,.videoplayer{margin:0 auto;max-width:650px}@media only screen and (max-width:480px){#gf-special-graphic .moreStories .stories .story{width:100%;float:none;margin:1em 0}}@media only screen and (min-width:1600px){.article-body .figure{margin-right:5%}}@media only screen and (min-width:1700px){.article-body .figure{margin-right:6.5%}}@media only screen and (min-width:1800px){.article-body .figure{margin-right:8%}}@media only screen and (min-width:1900px){.article-body .figure{margin-right:9.5%}}
</style>
<title>ImmunoGen&rsquo;s innovative &ldquo;payload platform&rdquo; powers potent Kadcyla breast cancer therapy - The Boston Globe</title>
<!-- Methode uuid: "e3c43f10-ef6a-11e3-8a49-f20cb1b355b9" -->
<script src="//cdn.blueconic.net/bostonglobemedia.js"></script>

	<meta property="og:latitude" content="42.40172099999999" />
			<meta property="og:longitude" content="-71.278975" />
			<meta property="og:streetaddress" content="830 Winter St" />
			<meta property="og:city" content="Waltham" />
			<meta property="og:state" content="MA" />
			<meta property="og:zip" content="02451" />
			<meta property="og:country" content="US" />
			<meta property="og:type" content="article"/>
	<meta property="og:description" content="The new breast cancer therapy Kadcyla depends on a innovative “payload platform” developed by ImmunoGen, which helps the drug bind to tumors and release targeted cancer-killing toxins that don’t harm surrounding healthy cells. "/>
	<meta property="og:title" content="ImmunoGen&rsquo;s innovative &ldquo;payload platform&rdquo; powers potent Kadcyla breast cancer therapy - The Boston Globe"/>
	<meta property="og:site_name" content="BostonGlobe.com" />
	<meta property="fb:admins" content="100001044693856" />
	<meta property="fb:admins" content="507486035" />
	<meta property="fb:app_id" content="103933749691726" />
	<meta property="fb:pages" content="5637143257" />
	<meta property="article:publisher" content="https://www.facebook.com/globe" />
	<link rel='apple-touch-icon' sizes='57x57' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-57x57.png'>
	<link rel='apple-touch-icon' sizes='60x60' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-60x60.png'>
	<link rel='apple-touch-icon' sizes='72x72' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-72x72.png'>
	<link rel='apple-touch-icon' sizes='76x76' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-76x76.png'>
	<link rel='apple-touch-icon' sizes='114x114' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-114x114.png'>
	<link rel='apple-touch-icon' sizes='120x120' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-120x120.png'>
	<link rel='apple-touch-icon' sizes='144x144' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-144x144.png'>
	<link rel='apple-touch-icon' sizes='152x152' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-152x152.png'>
	<link rel='apple-touch-icon' sizes='180x180' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-180x180.png'>

	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-16x16.png' sizes='16x16'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-32x32.png' sizes='32x32'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-96x96.png' sizes='96x96'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-194x194.png' sizes='194x194'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-192x192.png' sizes='192x192'>

	<link rel='mask-icon' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/safari-pinned-tab.svg' color='#000000'>

	<link rel="shortcut icon" type="image/gif" href="/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/favicon.ico" />

	<meta name='msapplication-TileColor' content='#ffffff'>
	<meta name='msapplication-TileImage' content='//c.o0bg.com/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/mstile-144x144.png'>
	<meta name='theme-color' content='#ffffff'>

	<!--[if gte IE 9 ]>
	<meta name="application-name" content="Homepage"/>
	<meta name="msapplication-tooltip" content="This is the tooltip"/>
	<meta name="msapplication-starturl" content="/?comp=9"/>
	<![endif]-->

	<!--[if lte IE 8 ]>
	<meta name="application-name" content="Boston Globe"/>
	<meta name="msapplication-TileColor" content="#000000"/>
	<meta name="msapplication-TileImage" content="25a75e8d-4542-40a4-80aa-253aea7efc28.png"/>
	<link rel="stylesheet" media="print" href="/css/globe-ie-print.css?v=18279I1728" type="text/css" />
	<![endif]-->

	<meta property="twitter:account_id" content="95431448" />
<meta name="robots" content="noarchive" />
<meta name="description" content="The new breast cancer therapy Kadcyla depends on a innovative “payload platform” developed by ImmunoGen, which helps the drug bind to tumors and release targeted cancer-killing toxins that don’t harm surrounding healthy cells. " />
<meta name="keywords" content="Kadcyla,ImmunoGen Inc.,Genentech,Roche AG,Dana-Farber Cancer Institute" />
<meta name="news_keywords" content="Kadcyla,ImmunoGen Inc.,Genentech,Roche AG,Dana-Farber Cancer Institute" />
<meta property="og:url" content="https://www.bostonglobe.com/business/2014/06/14/immunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy/bB4AyqiGL5ZSaYHw9EIUsK/story.html"/>
<link rel="canonical" href="https://www.bostonglobe.com/business/2014/06/14/immunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy/bB4AyqiGL5ZSaYHw9EIUsK/story.html" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:site" content="BostonGlobe" />
<link rel="amphtml" href="https://www.bostonglobe.com/business/2014/06/14/immunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy/bB4AyqiGL5ZSaYHw9EIUsK/amp.html" />
	<meta property="og:image" content="http://www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2014/06/10/BostonGlobe.com/Business/Images/immunogen-tease.jpg" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />
<meta name="viewport" content="width=device-width, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no" /> <!--[if gte IE 6]><link href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-print.css" rel="stylesheet"><![endif]-->
<!--[if !IE]><link href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-print.css?v=18279I1728" rel="stylesheet" media="only all"><![endif]-->
<!-- /business and story -->
<script src="/js/lib/jquery.js,dist/globe.js,dist/bglobesubs.js,dist/inline-newsletter.js,dist/brightcove-asset-loader.js,dist/globe-article.js?v=18279I1728"></script>
<link rel="stylesheet" type="text/css" media="all" href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-topic-nav.css,globe-comments.css?v=18279I1728"/>
<style>
html{font-size:100%;line-height:1.625em}body.type-internal div#contain{margin:0}footer.bg-footer{display:none}body{padding-bottom:0}#contain{width:100%;margin-bottom:0}#contain #main{margin:0}#contain .mod.live-update{display:none}.article{width:100%;float:none;margin:0;padding-top:0}.article .article-body{padding-bottom:2em}.article .article-body .skip-nav{display:none}.article .article-body .ad.aside{display:none}.article .lead-figure.full{display:none}.saved-panel{display:none}#masthead,.header,.byline,.primary-tools,.section-nav,.cats-first,.in-section{display:none}header.article-nav{box-sizing:border-box;-moz-box-sizing:border-box;width:100%;margin:0}header.article-nav .bostonGlobeLogo{margin-top:2em;text-align:center}header.article-nav .bostonGlobeLogo .bg-logo img{max-width:173px}header.article-nav .gameChangersLogo{text-align:center;margin-bottom:2em}header.article-nav .gameChangersLogo .gc-logo img{width:100%;max-width:300px}header.article-nav *{box-sizing:border-box;-moz-box-sizing:border-box}header.article-nav .topRow{height:100%;overflow:hidden;padding:.5em;border-bottom:1px solid #ccc}header.article-nav .topRow .leftNav{width:50%;float:left}header.article-nav .topRow .leftNav .categoryNav{font-family:Helvetica,Arial,sans-serif;width:171px;border:1px solid #ccc;z-index:999}header.article-nav .topRow .leftNav .categoryNav .categoryButton{background:#fff;font-weight:700;text-transform:uppercase;font-size:.8em}header.article-nav .topRow .leftNav .categoryNav .categoryButton a{display:block;color:#666;text-decoration:none;padding:.75em 0}header.article-nav .topRow .leftNav .categoryNav .categoryButton a .plus{background:#666;color:#fff;padding:1em}header.article-nav .topRow .leftNav .categoryNav ul{position:absolute;border:1px solid #ccc;font-weight:400;border-top:none;width:170px}header.article-nav .topRow .leftNav .categoryNav ul li{background:#fff;color:#444;font-size:.8em;border-top:1px solid #ccc}header.article-nav .topRow .leftNav .categoryNav ul li a{padding:.75em .5em;display:block;text-decoration:none}header.article-nav .topRow .leftNav .categoryNav ul li:hover{background:#eee}header.article-nav .topRow .leftNav .categoryNav ul.hide{display:none}header.article-nav .topRow .leftNav .categoryNav .upTopCategory{position:absolute;width:100%;max-width:720px;background:#fff;border:1px solid #ccc;border-top:none;margin-top:.75em;left:0;padding:.5em;box-shadow:2px 1px 2px #ccc}header.article-nav .topRow .leftNav .categoryNav .upTopCategory .close{text-align:right}header.article-nav .topRow .leftNav .categoryNav .upTopCategory .close a{text-decoration:none;font-weight:700;text-transform:uppercase;font-size:.9em}header.article-nav .topRow .leftNav .categoryNav .upTopCategory .categoryLabel{font-weight:700;font-size:.9em}header.article-nav .topRow .leftNav .categoryNav .upTopCategory.hide{display:none}header.article-nav .topRow .rightNav{width:50%;text-align:right;float:left}header.article-nav .topRow .rightNav .globe-account{font-size:13px;font-family:Helvetica,Arial,sans-serif;text-transform:uppercase}header.article-nav .topRow .rightNav .globe-account a{line-height:44px;vertical-align:-webkit-baseline-middle;vertical-align:-moz-baseline-middle;vertical-align:baseline-middle;margin-left:.5em;color:#aaa;text-decoration:none}header.article-nav .topRow .rightNav .globe-account a:hover{color:#666}header.article-nav .topRow .stories{height:100%;overflow:hidden}header.article-nav .topRow .stories .story{box-sizing:border-box;-moz-box-sizing:border-box;text-align:left;width:50%;float:left;margin:.5em 0;height:80px;line-height:1.4}header.article-nav .topRow .stories .story a{height:100%;overflow:hidden;display:block;font-family:Helvetica,Arial,sans-serif;text-decoration:none;font-weight:400;padding-right:1.5em;color:#666;font-size:.9em}header.article-nav .topRow .stories .story img{max-height:80px;width:30%;display:block;float:left}header.article-nav .topRow .stories .story span{padding:0 .5em;display:block;width:70%;float:left}header.article-nav .articleInfo{text-align:center}header.article-nav .articleInfo .newHeadline{font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;font-size:2em;line-height:1.2;padding:0 .5em}header.article-nav .articleInfo .newByline{margin-bottom:1em}header.article-nav .articleInfo .newByline a{font-size:.8em;font-weight:700;text-decoration:none}header.article-nav .articleInfo .newByline cite{font-style:none}header.article-nav .articleInfo .figcaption{margin:0 auto;max-width:960px}header.article-nav .articleInfo .figcaption p{max-width:100%;text-align:left}header.article-nav .articleInfo .figcaption p.credit{text-align:right}header.article-nav .rightNav .commentSection img{max-width:16px}@media only screen and (max-width:480px){header.article-nav .articleInfo .newHeadline{font-size:1.4em}header.article-nav .gameChangersLogo{max-width:240px;margin:0 auto;margin-bottom:2em}header.article-nav .topRow .leftNav .categoryNav{display:none}header.article-nav .topRow .rightNav{width:100%}header.article-nav .topRow .rightNav .globe-account a{line-height:37px}}a.global-bar{display:none}.article-body *,.article-body *:before,.article-body *:after,header{-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box}.article-body{margin:0}.article-body .lead{position:relative}.article-body .lead img{width:100%}.article-body .lead .headerContainer{position:absolute;top:0;left:0;margin-left:33%;margin-top:11%;color:#fff;text-align:left;opacity:.9;text-shadow:0 2px 0 rgba(0,0,0,.3)}.article-body .lead .headerContainer .title{line-height:1.1;font-size:4.6em;font-family:"Miller Headline Roman","Times New Roman",Times,Georgia,serif;font-weight:400;margin-bottom:.4em;margin-right:2%}.article-body .lead .headerContainer .author a{color:#fff;font-size:1.3em;font-family:Georgia,"Times New Roman",Times,serif;font-weight:400;margin:0}.article-body .lead .headerContainer .author a span{text-transform:uppercase;font-size:.8em}.article-body p{max-width:720px;width:100%;margin:0 auto 1.125em auto}.article-body p:nth-child(3)::first-letter{font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;float:left;display:block;font-size:5em;color:#000;padding:0;margin:0;margin-right:.1em;line-height:1}.article-body p span.linebreak{display:block;height:1px;background:#ccc;margin:2.5em 0}.article-body p span.timeStamp{display:block;padding-top:2em;color:#aaa;font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;font-weight:300;font-size:.8em;text-transform:uppercase}.article-body p span.attributionBox{font-style:italic}.article-body p span.uppercase{text-transform:uppercase}.article-body .tease a{color:#000}.article-body .tease:visited{color:#000}.article-body .tease:hover{color:#96101E}.article-body .wide{max-width:720px;margin:0 auto;text-align:center}.article-body .wide .figcaption p{text-align:left}.article-body .wide .figcaption p.credit{text-align:right}.article-body .figure{margin-right:1em;max-width:320px}.article-body .columnWidth{width:100%;padding:0 1em}.article-body .centerText{text-align:center}.article-body em:last-child{display:block;max-width:720px;margin:0 auto;padding:0 .5em}.sourceCredits{text-align:right;max-width:720px;padding:1em .5em;font-size:.75em;font-weight:700;margin:0 auto}.sourceCredits .credits{font-weight:400;color:#aaa;text-align:right;text-transform:uppercase;font-size:.8em;letter-spacing:.05em}.sourceCredits .source{text-align:left}@media only screen and (max-width:730px){.article-body p{padding:0 1em}}#gf-special-graphic{max-width:960px;width:100%;margin:0 auto;padding-bottom:2em}#gf-special-graphic .sharing,#gf-special-graphic .social{font-family:Helvetica,Arial,sans-serif;text-transform:uppercase;color:#999;font-weight:400;font-size:.9em;text-align:center;margin:.5em 0}#gf-special-graphic .sharing a,#gf-special-graphic .social a{text-decoration:none}#gf-special-graphic .sharing img,#gf-special-graphic .social img{margin:.5em;max-height:32px}#gf-special-graphic .moreStories{margin-top:2em;font-family:"Benton Sans Bold",Helvetica,Arial,sans-serif;text-align:center;font-weight:700;padding:0 .5em}#gf-special-graphic .moreStories .categories{max-width:720px;margin:0 auto}#gf-special-graphic .moreStories .categories .label{font-family:Helvetica,Arial,sans-serif;border:1px solid #ccc;text-transform:uppercase;font-size:.8em;color:#666;font-weight:700;text-align:left;display:block;text-decoration:none;margin:.5em 0;padding:.75em 0}#gf-special-graphic .moreStories .categories .label:before{content:'+';margin-right:.25em;background:#666;color:#fff;padding:1em}#gf-special-graphic .moreStories .categories .label.hide:before{content:'-'}#gf-special-graphic .moreStories .stories{height:100%;overflow:hidden}#gf-special-graphic .moreStories .stories .story{box-sizing:border-box;-moz-box-sizing:border-box;text-align:left;width:50%;float:left;margin:.5em 0;height:80px;line-height:1.2}#gf-special-graphic .moreStories .stories .story a{height:100%;overflow:hidden;display:block;font-family:Helvetica,Arial,sans-serif;text-decoration:none;font-weight:400;padding-right:1.5em;color:#666;font-size:.9em}#gf-special-graphic .moreStories .stories .story img{max-height:80px;width:30%;display:block;float:left}#gf-special-graphic .moreStories .stories .story span{padding:0 .5em;display:block;width:70%;float:left}#gf-special-graphic .moreStories .stories.hide{display:none}.BrightcoveExperience,.videoplayer{margin:0 auto;max-width:650px}@media only screen and (max-width:480px){#gf-special-graphic .moreStories .stories .story{width:100%;float:none;margin:1em 0}}@media only screen and (min-width:1600px){.article-body .figure{margin-right:5%}}@media only screen and (min-width:1700px){.article-body .figure{margin-right:6.5%}}@media only screen and (min-width:1800px){.article-body .figure{margin-right:8%}}@media only screen and (min-width:1900px){.article-body .figure{margin-right:9.5%}}
</style>
<!-- oas_sitepage:www.bostonglobe.com/business/homepage -->
<!-- webtype is story section is  adPageType article oas_sitepage www.bostonglobe.com/business/homepage-->

<!-- taxonomy: Business/Innovation rank: 103001 lowestRank: 103001 section: /business -->
		<!--  lowestRank: 103001 taxonomy: Business/Innovation section: /business -->

		<!-- admode:  smode  -->
		<script type="text/javascript">
      var googletag = googletag || {};
      googletag.cmd = googletag.cmd || [];

      function oxDone() {
        var gads = document.createElement("script");
        gads.async = true;
        gads.type = "text/javascript";
        gads.src = "//www.googletagservices.com/tag/js/gpt.js";
        var node = document.getElementsByTagName("script")[0];
        node.parentNode.insertBefore(gads, node);
      }

      
      var OX_dfp_ads = [];

    </script>

    <!-- modAdunit: bostonglobe.com/business  -->
    <script>
    	  var globe = globe || {};
	      globe.dfp = {
	        networkCode: 61381659
	      };

          globe.dfp.keyValuePairs = {
            s1: 'bostonglobe.com',
            s2: 'business',
            s3: '',
            s4: '',
            pgtype: 'article',
            pageurl: '_business_2014_06_14_immunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy_bB4AyqiGL5ZSaYHw9EIUsK_story_html',
            meta: "Kadcyla,ImmunoGen_Inc_,Genentech,Roche_AG,Dana-Farber_Cancer_Institute",
            weather: "",
            temp: "",
            aam: ""
        }
        globe.dfp.adUnit = 'bostonglobe.com/business';
    </script>
<!-- Facebook Pixel Code -->
<script>
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()
{n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
;if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
document,'script','https://connect.facebook.net/en_US/fbevents.js');
fbq('init', '884869448226452');
fbq('track', "PageView");</script>
<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=884869448226452&ev=PageView&noscript=1"
/></noscript>
<!-- End Facebook Pixel Code -->
</head>

<body itemscope itemtype="http://schema.org/WebPage" class='type-internal type-article section-business business type-business logged-out'>

<div id="contain">
<!-- type:EOM::CompoundStory autosection: section class:Business section:/business-->
<!-- topSection2 /business -->

<header class="bg-header clearfix">
	<div class="bg-header__subinfo bg-header__subinfo--tablet">
		<div class="js-user-subscribe" data-baseurl="https://www.bostonglobe.com"></div>
			</div>
	    <div id="smartbar" class="bg-header__smartbar" data-hide-on-load="true">
	       <a href="" class="bg-header__smartbar--message" onClick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar15,channel,prop1';s.linkTrackEvents='none';s.tl(this,'o','BG Header - Smart Bar_Marketing Gen');" data-logged-in-message='<span class="bg-header__smartbar--text-bold">Season Ticket</span> <span class="bg-header__smartbar--text">Listen now to the new sports podcast</span>' data-logged-in-link='https://bostonglobe.com/seasonticket' data-logged-out-message='<span class="bg-header__smartbar--text-bold">SUBSCRIBE NOW</span> <span class="bg-header__smartbar--text">Get unlimited access to Globe.com today</span>' data-logged-out-link='http://subscribe.bostonglobe.com/B6455/?p1=BGHeader_SmartBar_Marketing_Sub'>
	</a>
</div>
	<div class="bg-header__menus">
		<a href="#" class="bg-header__button bg-header__hamburger js-open-menu" onclick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','BG Menu - Open');">Menu</a>
		<a href="/?p1=BGHeader_Logo" class="bg-header__button bg-header__home"></a>
	</div>

	<div class="bg-header__subinfo">
	<div class="js-user-settings" data-location="" data-baseurl="https://www.bostonglobe.com"></div>
			<div class="js-user-subscribe" data-location="" data-baseurl="https://www.bostonglobe.com"></div>
		</div>

<a href="/business?p1=BGHeader_SectionLink" class="bg-header__centerpiece bg-header__logo-wrapper">
               <div class="bg-header__logo"></div>
			<div class="bg-header__section-front">Business</div>

			</a>
		<nav class="bg-header__takeover" aria-hidden="true">
				<div class="bg-header__takeover-full-screen">
					<div class="bg-header__menu-wrapper">
	   					<div class="bg-header__close js-close-menu">
		   				</div>
		   				<a href="" class="bg-header__home"></a>

			   			<!-- Logged out Subinfo -->
						<div class="bg-header__subinfo">
	<div class="js-user-settings" data-location="menu" data-baseurl="https://www.bostonglobe.com"></div>
			<div class="js-user-subscribe" data-location="menu" data-baseurl="https://www.bostonglobe.com"></div>
		</div>

<a href="/?p1=BGMenu_Logo" class="bg-header__logo"></a>

						<div class="bg-header__menu">
							<section class="bg-header__menu-left">
								<ul class="bg-header__sections">
									<li class="bg-header__section">
													<a href="/metro?p1=BGMenu" class="bg-header__link">Metro</a>
												</li>
											<li class="bg-header__section">
													<a href="/sports?p1=BGMenu" class="bg-header__link">Sports</a>
												</li>
											<li class="bg-header__section">
													<a href="/business?p1=BGMenu" class="bg-header__link">Business & Tech</a>
												</li>
											<li class="bg-header__section">
													<a href="/opinion?p1=BGMenu" class="bg-header__link">Opinion</a>
												</li>
											<li class="bg-header__section">
													<a href="/news/politics?p1=BGMenu" class="bg-header__link">Politics</a>
												</li>
											<li class="bg-header__section">
													<a href="/lifestyle?p1=BGMenu" class="bg-header__link">Lifestyle</a>
												</li>
											<li class="bg-header__section">
													<a href="/arts?p1=BGMenu" class="bg-header__link">Arts</a>
												</li>
											<li class="bg-header__section">
													<a href="http://www.boston.com/section/cars" class="bg-header__link"
														target="_blank"
														onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Menu - Nav - Cars');">
														Cars</a>
												</li>
											<li class="bg-header__section">
													<a href="http://realestate.boston.com" class="bg-header__link"
														target="_blank"
														onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Menu - Nav - Real Estate');">
														Real Estate</a>
												</li>
											</ul>
							</section>
							<section class="bg-header__menu-right">
								<div class="bg-header__recommended">
									<p class="bg-header__recommended-header">
										Most popular on BostonGlobe.com
									</p>
									<p class="bg-header__recommended-subhead">Based on what you&#39;ve read recently, you might be interested in theses stories</p>
								</div>
								<div class="bg-header__suggestions">
		<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/sports/redsox/2017/10/09/shaughnessy/EK3NwkqZneeTdMOnc8qr0N/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/09/BostonGlobe.com/ReceivedContent/Images/Grossfeld4ALDS2.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Dan Shaughnessy: Red Sox stars did not deliver when it mattered most</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/lifestyle/names/2017/10/09/report-matt-damon-helped-kill-earlier-new-york-times-story-about-harvey-weinstein/2TDJnvLT0eDq9HhuvdmXjP/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/09/19/BostonGlobe.com/Lifestyle/Images/06196800.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Report: Matt Damon helped kill earlier New York Times story about Harvey Weinstein</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/metro/2017/10/04/rex-tillerson-secretary-bleeping-state-chaos/TyU9L2FmqJBkpJcNcui5VJ/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/04/BostonGlobe.com/Metro/Images/Rex_US_Secretary_of_State_Rex_Tiller_9114668V.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Rex Tillerson, secretary of a (bleeping) state of chaos</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/business/2017/10/09/homeowner-deck-nightmare/C7IN6Ej7pNmNASrIz7ormI/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/09/BostonGlobe.com/Business/Images/consumerwiggs_Home_02.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Homeowner’s deck nightmare</figcaption>
	 					</a>
		   			</figure>
				</div>
<form action="/queryResult/search" class="bg-header__search" method="get" role="search">
						        <div class="search-inputs">
									<input type="text" class="bg-header__input" id="q" placeholder="Search BostonGlobe.com" role="search" name="q">
								</div>
							</form>
							</section>
							<ul class="bg-header__more-sections">
								<li class="bg-header__section">
										<a href="/todayspaper?p1=BGMenu_Subnav" class="bg-header__link">Today's Paper</a>
									</li>
								<li class="bg-header__section">
										<a href="/magazine?p1=BGMenu_Subnav" class="bg-header__link">Magazine</a>
									</li>
								<li class="bg-header__section">
										<a href="/metro/obituaries?p1=BGMenu_Subnav" class="bg-header__link">Obituaries</a>
									</li>
								<li class="bg-header__section">
										<a href="http://www.boston.com/weather?p1=BGMenu_Subnav" class="bg-header__link">Weather</a>
									</li>
								<li class="bg-header__section">
										<a href="/lifestyle/comics?p1=BGMenu_Subnav" class="bg-header__link">Comics</a>
									</li>
								<li class="bg-header__section">
										<a href="/lifestyle/crossword?p1=BGMenu_Subnav" class="bg-header__link">Crossword</a>
									</li>
								<li class="bg-header__section">
										<a href="/news/bigpicture?p1=BGMenu_Subnav" class="bg-header__link">The Big Picture</a>
									</li>
								</ul>
						</div>
						<aside class="bg-header__pop-up" aria-hidden="true">
					   		<div class="bg-header__close-pop-up js-close-pop-up"></div>
					   		<div class="bg-header__caret-wrapper"><div class="bg-header__caret"></div></div>
					   		<section class="bg-header__pop-up-section bg-header__pop-up-section--digital">
						   		<img src="/img/masthead/lockup.png" class="bg-header__sub-img"/>
					   			<p class="bg-header__sub-title">Digital Access</p>
					   			<p class="bg-header__promo-text">99 cents a week for the first 4 weeks</p>
								<a href="https://subscribe.bostonglobe.com/B3853/?eglobe_rc=WW20167D&p1=BGMenu_DigitalSubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe Digital');">Subscribe</a>
								<a href="https://subscribe.bostonglobe.com/B3853/?rc=WW20167D&eglobe_rc=WW20167D&p1=BGMenu_DigitalSubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe Digital');">Subscribe</a>				   			</section>
					   		<section class="bg-header__pop-up-section bg-header__pop-up-section--delivery">
					   			<img src="/img/masthead/newspaper.png" class="bg-header__sub-img"/>
					   			<p class="bg-header__sub-title">Home Delivery</p>
					   			<p class="bg-header__promo-text">Save 50% off the regular rate</p>
								<a href="//homedelivery.bostonglobe.com/hd/26/order/zip/?rc=WW011964&globe_rc=WW011964&p1=BGMenu_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe HD');">Subscribe</a>
		   						<a href="https://subscribe.bostonglobe.com/B8554/?rc=WW011964&globe_rc=WW011964&p1=BGMenu_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe HD');">Subscribe</a>
					   		</section>
				   			<span class="bg-header__sub-login">Already a subscriber? <a href="https://www.bostonglobe.com/login?p1=BGMenu_Login_Link" class="bg-header__sub-click" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar27,events';s.linkTrackEvents='event15';s.eVar27='BG Menu Modal';s.events='event15';s.tl(this,'o','BG Menu Modal - Log In');">Members Sign In</a></span>
				   		</aside>
	   				</div>
	   			</div>
   			</nav>



   	<aside class="bg-header__pop-up" aria-hidden="true">
   		<div class="bg-header__close-pop-up js-close-pop-up"></div>
   		<div class="bg-header__caret-wrapper"><div class="bg-header__caret"></div></div>
   		<section class="bg-header__pop-up-section bg-header__pop-up-section--digital">
   			<img src="/img/masthead/lockup.png" class="bg-header__sub-img"/>
   			<p class="bg-header__sub-title">Digital Access</p>
   			<p class="bg-header__promo-text">99 cents a week for the first 4 weeks</p>
		    <a href="https://subscribe.bostonglobe.com/B3605/?eglobe_rc=WW20145D&p1=BGHeader_DigitalSubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	Digital');">Subscribe</a>
			<a href="https://subscribe.bostonglobe.com/B3605/?rc=WW20145D&eglobe_rc=WW20145D&p1=BGHeader_DigitalSubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	Digital');">Subscribe</a>

   		</section>
   		<section class="bg-header__pop-up-section bg-header__pop-up-section--delivery">
   			<img src="/img/masthead/newspaper.png" class="bg-header__sub-img"/>
   			<p class="bg-header__sub-title">Home Delivery</p>
   			<p class="bg-header__promo-text">Save 50% off the regular rate</p>
			<a href="//homedelivery.bostonglobe.com/hd/26/order/zip/?rc=WW011964&globe_rc=WW011964&p1=BGHeader_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	HD');">Subscribe</a>
			<a href="https://subscribe.bostonglobe.com/B0004/?rc=WW011964&globe_rc=WW011964&p1=BGHeader_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	HD');">Subscribe</a>
   		</section>
   		<span class="bg-header__sub-login">Already a subscriber? <a href="https://www.bostonglobe.com/login?p1=BGHeader_Login_Link" class="bg-header__sub-click" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar27,events';s.linkTrackEvents='event15';s.eVar27='BG Header Modal';s.events='event15';s.tl(this,'o','BG Header Modal - Log In');">Members Sign In</a></span>
   	</aside>

</header>
<!-- story_default.jpt, story id:600ef2ac-ec20-11e3-88f3-8609f4775199 path:/Boston/2011-2020/2014/04/17/BostonGlobe.com/Business/Stories -->

		<div class="ad billboard" id="ad_outofpage2"></div>  <div class="ad billboard" id="ad_billboard"></div>  <div class="mod live-update">
			</div>

		<main id="main" role="main" class="eptClick">
			<article class="article" itemscope="itemscope"
				itemtype="http://schema.org/NewsArticle">
				<meta itemprop="inLanguage" content="en-US" />
				<meta itemprop="genre" content="news" />
				<meta itemprop="articleSection" content="Business" />
				<!-- Headline Section -->
				<header>
	<div class="header new">
	<h1 class="main-hed" itemprop="headline">ImmunoGen’s breast cancer therapy took time</h1>
	<h2 class="subhed">Payoff after 30 years of work</h2>	
	</div>
	
	</header>
<div class="article-body">
					<!-- position:Top -->
<!--
METADATA FOR EMTAF
      <headline>ImmunoGen’s breast cancer therapy took time</headline>
      <source>Globe Staff</source>
      <teasetext>Kadcyla made its market debut last year, following a long and winding journey to approval for what many view as a miracle medicine.</teasetext>
      <byline>By Robert Weisman</byline>
      <date>20140615040000</date>
-->

<aside class="tools">
	<ul class="Top tools primary-tools">
		<!-- imgAltCaption: Ravi Chari (top) and John Lambert helped to develop Kadcyla at ImmunoGen. -->
		<li class="email">
	      <a class="bg-button--email email" onClick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Email_Top');" data-omniture="BG Article Share Tools - Email - Top" target="_blank" title="Share via E-mail" aria-label="Share via E-mail" href="#"><span class="bg-icon--email">E-Mail</span></a>
	      <div class="email-form">
				<h4>Share via e-mail</h4>
				<div class="email-error"></div>
				<form action="" method="post">
					<input type="hidden" id="story_url-Top" name="story_url" value="http://www.bostonglobe.com/business/2014/06/14/immunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy/bB4AyqiGL5ZSaYHw9EIUsK/story.html"/>
					<p>
						<label for="email-to-primary-Top">To</label>
						<input type="text" name="email-to-primary" id="email-to-primary-Top" placeholder="Separate multiple addresses with a comma" />
					</p>
					<p>
						<label for="email-mssg-primary-Top">Add a message</label>
						<textarea name="email-mssg-primary" id="email-mssg-primary-Top" maxlength="80" placeholder="80 character limit"></textarea>
					</p>
					<p>
						<label for="email-from-primary-Top">Your e-mail</label>
						<input type="text" name="email-from-primary" id="email-from-primary-Top" />
					</p>
					<input type="submit" value="Send" class="bg-button" onClick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Send_Top');"/>
				</form>
			</div><!-- /end .email-form -->
	    </li>
	    <li>
	      <a class="bg-button--fb" data-omniture="BG Article Share Tools - Facebook - Top" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2014%2F06%2F14%2Fimmunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy%2FbB4AyqiGL5ZSaYHw9EIUsK%2Fstory.html%3Fevent%3Devent25&amp;t=ImmunoGen’s breast cancer therapy took time" target="_blank" title="Share on Facebook" aria-label="Share on Facebook"><span class="bg-icon--fb">Facebook</span></a>
	    </li>
	    <li>
	      <a class="bg-button--twitter" data-omniture="BG Article Share Tools - Twitter - Top" href="http://twitter.com/intent/tweet?text=ImmunoGen’s breast cancer therapy took time&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2014%2F06%2F14%2Fimmunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy%2FbB4AyqiGL5ZSaYHw9EIUsK%2Fstory.html%3Fevent%3Devent25&amp;via=BostonGlobe" target="_blank" title="Share on Twitter" aria-label="Share on Twitter"><span class="bg-icon--twitter">Twitter</span></a>
	    </li>
	    <li>
			<a class="bg-button--gplus" data-omniture="BG Article Share Tools - Google+ - Top" href="https://plus.google.com/share?url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2014%2F06%2F14%2Fimmunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy%2FbB4AyqiGL5ZSaYHw9EIUsK%2Fstory.html%3Fevent%3Devent25%26s_campaign%3dsm_gp%26hl=en-US" target="_blank" title="Share on Google+" aria-label="Share on Google+"><span class="bg-icon--gplus">Google+</span></a>
				</li>
	    <li>
	      <a class="bg-button--linkedin" data-omniture="BG Article Share Tools - Linkedin - Top" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2014%2F06%2F14%2Fimmunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy%2FbB4AyqiGL5ZSaYHw9EIUsK%2Fstory.html%3Fevent%3Devent25&amp;title=ImmunoGen’s breast cancer therapy took time&amp;summary=Kadcyla+made+its+market+debut+last+year%2C+following+a+long+and+winding+journey+to+approval+for+what+many+view+as+a+miracle+medicine." target="_blank" title="Share on LinkedIn" aria-label="Share on LinkedIn"><span class="bg-icon--linkedin">LinkedIn</span></a>
	    </li>
	</ul>
	<a href="#comments" class="js-comments-toggle bg-button--generic">
		  <span class="bg-icon-comment-dark bg-icon--small"></span>
		  <span class="js-comment-count"></span> <span class="js-comment-count-label bg-visuallyhidden">Comments</span>
		</a>

	<a class="bg-button--generic bg-button--print" onclick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Print_Top')" href="javascript:print();">
			<span class="bg-icon--print bg-icon--small"></span>
			<span class="bg-visuallyhidden">Print</span></a>
		</aside>
<div class="sticky-tools">
		<a class="sticky-tools__button sticky-tools__button--home" href="/?p1=BGHeader_Logo_Sticky">
		    <span>The Boston Globe</span>
		</a><a class="sticky-tools__button sticky-tools__button--share tw" data-omniture="BG Article Share Tools - Twitter - Sticky" href="http://twitter.com/intent/tweet?text=ImmunoGen’s breast cancer therapy took time&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2014%2F06%2F14%2Fimmunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy%2FbB4AyqiGL5ZSaYHw9EIUsK%2Fstory.html%3Fevent%3Devent25%3Fevent%3Devent25&amp;via=BostonGlobe" target="_blank" title="Share on Twitter">
		    <span>Tweet</span>
		</a><a class="sticky-tools__button sticky-tools__button--share fb" data-omniture="BG Article Share Tools - Facebook - Sticky" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2014%2F06%2F14%2Fimmunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy%2FbB4AyqiGL5ZSaYHw9EIUsK%2Fstory.html%3Fevent%3Devent25%3Fevent%3Devent25&amp;tImmunoGen’s breast cancer therapy took time" target="_blank" title="Share on Facebook">
		    <span>Share</span>
		</a><a class="sticky-tools__button sticky-tools__button--share sticky-comments js-sticky-comments" href="#comments">
		    <span></span>
		    <p class="js-comment-count sticky-comments-count"></p>
		    <p class="js-comment-count-label sticky-comments-count-label"></p>
		</a>
		<div class="sticky-tools__button sticky-tools__button--top js-back-to-top"></div>
	</div>
<!-- Header Tabs Section -->
					<figure itemprop="associatedMedia" itemscope itemtype="http://schema.org/ImageObject" class="figure lead-figure full">
		<img  itemprop="contentUrl" src="//www.bostonglobe.com/rf/image_r/Boston/2011-2020/2014/06/11/BostonGlobe.com/Business/Images/immunogen-big-7629.r.jpg" data-fullsrc="//c.o0bg.com/rf/image_960w/Boston/2011-2020/2014/06/11/BostonGlobe.com/Business/Images/immunogen-big-7629.jpg" alt="Ravi Chari (top) and John Lambert helped to develop Kadcyla at ImmunoGen."/>
		<figcaption class="figcaption">
			<meta itemprop="creator" content="Essdras M Suarez" />
			<p class="credit">Essdras M Suarez/Globe Staff</p>
			<p itemprop="description caption">Ravi Chari (top) and John Lambert helped to develop Kadcyla at ImmunoGen.</p>
		</figcaption>
	</figure>	
<div class="byline">
	<b class="author"><!---->By <a class="" title="More Stories by Robert Weisman" href="/staff/weisman" rel="author"><span itemprop="name">Robert Weisman</span></a></b>
	Globe Staff&nbsp;
	<time itemprop="datePublished" datetime="2014-06-15 04:00">June 15, 2014</time>
	<p></p>
	<p></p>
</div><div class="article-text" itemprop="articleBody">
						<!-- leading video or graphic -->
						<!-- inside story_update.jpt -->
<!-- In Story Photo or Graphic Section -->
							<!-- paragraphs 12 leadingContainer photo
										leadingShape horizontal hasRBox false -->
									<!----><p>
<div class="multimedia-template">
<header class='article-nav'>
	<div class='topRow'>
		<div class='leftNav'>
			<div class='categoryNav'>
				<div class='categoryButton'>
					<a href='#'>
						<span class='plus'>+</span>
						View Categories
					</a>
				</div>
				<ul class='hide'>
					<li><a href='#technology' data-category='technology'>Technology</a></li>
					<li><a href='#medicine' data-category='medicine'>Medicine &amp; Medical</a></li>
					<li><a href='#design' data-category='design'>Design &amp; Transportation</a></li>
					<li><a href='#finance' data-category='finance'>Finance &amp; Nonprofits</a></li>
					<li><a href='#beta' data-category='beta'>Beta Boston</a></li>
				</ul>
				<div class='upTopCategory hide'>
					<div class='categoryLabel'></div>
					<div class='categoryContent'></div>
					<div class='close'>
						<a href='#'>Close</a>
					</div>
				</div>
			</div>
		</div>
		<div class='rightNav'>
			<div class='globe-account'></div>
		</div>
	</div>
	<div class='bostonGlobeLogo'>
		<a class='bg-logo' href='http://bostonglobe.com' title='The Boston Globe'>
			<img src='http://cache.boston.com/multimedia/graphics/projectFiles/2014/special/logo-bg.png'>
		</a>
	</div>
	<div class='gameChangersLogo'>
		<a class='gc-logo' href='http://bostonglobe.com/gamechangers'>
			<img alt='Boston Globe - Game Changers' title='Boston Globe - Game Changers' src='http://cache.boston.com/multimedia/graphics/projectFiles/2014/special/game-changers-logo.jpg'>
		</a>
	</div>
	<div class='articleInfo'>
		<h1 class='newHeadline'></h1>
		<div class='newByline'></div>
		<div class='newLeadImage'></div>
	</div>
</header>
</div>
</p><p>Patients and doctors applauded last year when the powerful new breast cancer therapy Kadcyla made its market debut, following a long and winding journey to approval for what many view as a miracle medicine.</p><p>The Genentech division of Swiss drug giant Roche AG got the nod from US and European regulators to sell Kadcyla. But the innovative &ldquo;payload platform&rdquo; that enables the drug to bind to tumors &mdash; releasing targeted, cancer-killing toxins that don&rsquo;t harm surrounding healthy cells &mdash; was painstakingly developed over three decades by ImmunoGen of Waltham.</p><p class="skip-nav article-more">
	<a>Advertisement</a>
	</p>

<div class="ad aside" id="ad_bigbox1"></div>  <a id="skip-target1"></a>

<p>&ldquo;It was 30 years of beavering away,&rdquo; said chief scientific officer John Lambert, who was ImmunoGen&rsquo;s second employee.</p><p>In the early 1980s, the dawn of the biotechnology age, scientists and investors saw the potential to exploit a type of protein known as monoclonal antibodies to deliver toxic chemicals directly to tumors. ImmunoGen was spun out of the Dana-Farber Cancer Institute&rsquo;s predecessor hospital in Boston to investigate the concept.</p><figure class="figure" itemtype="http://schema.org/ImageObject" itemprop="associatedMedia">
<img alt="Bob Lutz, vice president of translational research and development at ImmunoGen." data-fullsrc="//c.o0bg.com/rf/image_460w/Boston/2011-2020/2014/06/11/BostonGlobe.com/Business/Images/lutz-side.jpg" src="//c.o0bg.com/rf/image_r/Boston/2011-2020/2014/06/11/BostonGlobe.com/Business/Images/lutz-side.r.jpg" itemprop="url"><figcaption class="figcaption">
<p class="credit">Essdras M Suarez/Globe Staff</p>
<p>Bob Lutz, vice president of translational research and development at ImmunoGen.</p>
</figcaption>
</figure><p></p><div class="inline-newsletter" data-exact-target-ID="20712964" data-mailing-list-name="Talking Points" data-is-amp="" data-section="/business">
  <div class="inline-newsletter__network-error"></div>
  <div class="inline-newsletter__copy">
    <div class="inline-newsletter__title">
      Get <span class="inline-newsletter__bold">Talking Points</span> in your inbox:
    </div>
    <div class="inline-newsletter__description">
        An afternoon recap of the day’s most important business news, delivered weekdays.</div>
    </div>
  <form class="inline-newsletter__content" method="post">
    <div class="inline-newsletter__error-text"></div>
    <input placeholder="Enter email address" type="text" id="inline-newsletter-email-input" class="inline-newsletter__input">

    <div class="inline-newsletter__button-container">
      <button class="inline-newsletter__button">
        <span class="inline-newsletter__button-text">Sign Up</span>
      </button>
      <div class="inline-newsletter__spinner"></div>
    </div>
  </form>
  <div class="inline-newsletter__thanks">
    Thank you for signing up!
    <a href="/newsletters?p1=Article_inline-newsletterWidget_ThankYou_Link" class="inline-newsletter__link">Sign up for more newsletters here</a>
    </div>
</div>

<p>After several dead ends, its researchers created a &ldquo;linkable derivative&rdquo; of maytansine, a compound extracted from the bark of an African tree. &ldquo;It gave us a chemical handle,&rdquo; Lambert recalled. &ldquo;Now we had something we could put on cancer cells and kill them.&rdquo;</p><!-- total:0 -->

<p>But scientists still had to find a way to link that derivative to an antibody and a method of getting the combined payload into the targeted tumor cells. That work would give birth to a new class of drugs, complete with their own delivery system. They were called antibody-drug conjugates.</p><p>It took many more years to overcome the technical challenges. Once they were met, Lambert wrote to scientists at Genentech, which had won approval for its breast cancer drug Herceptin in 1998. By using ImmunoGen&rsquo;s linker and delivery system, he said, &ldquo;we could turn a drug into a superdrug.&rdquo;</p><!--  working ad -->
<p class="skip-nav article-more">
	<a>Advertisement</a>
	<!-- <a href="#skip-target2">Continue reading below</a> -->
</p>
<!-- adLayerPath: /Boston/Production/BostonGlobe.com/WebPages/Homepage/homepage.ad-layer.story-asset.dwp -->
<div class="ad aside" id="ad_bigbox2"></div>  <a id="skip-target2"></a>

<p>After what Lambert describes as &ldquo;a four-year dance,&rdquo; Genentech licensed the ImmunoGen technology. Early last year, Kadcyla became the first antibody-drug conjugate to win full approval from the Food and Drug Administration.</p><p>In the process, it positioned the technology platform to become a growing force in cancer drug research. ImmunoGen itself has nine other experimental drugs &mdash; three wholly owned and six in partnerships &mdash; using the same approach.</p><p>&ldquo;Kadcyla&rsquo;s approval was a validating event,&rdquo; said ImmunoGen chief executive Daniel M. Junius. &ldquo;Patients are seeing clear efficacy with better tolerability.&rdquo;</p><p>Lorraine Heidke-McCartin, a Hanson woman diagnosed with HER2-positive breast cancer in 2006, was treated with more than a dozen drugs &mdash; many causing severe side effects &mdash; before she began taking the drug candidate that was to become Kadcyla, under an expanded access program in late 2010. Her tumors and swollen lymph nodes quickly began to shrink, and since the end of 2011, her doctors have seen no sign of the disease.</p><p>&ldquo;It&rsquo;s been a blessing,&rdquo; said Heidke-McCartin, who works at a Holbrook church and baby-sits her seven grandchildren. &ldquo;Previously I was fighting a losing battle. By putting the poison right where it needs to be and not throughout the body, this drug has made so much difference for patients. You don&rsquo;t lose your hair, you don&rsquo;t have all the side effects. I can live my life.&rdquo;</p><p>
<div class="multimedia-template">
<div id='gf-special-graphic'>
	<div class='sharing'>
		Share this story
	</diV>
	<div class='social'>
		<a class='twitter' href=''>
			<img src='http://cache.boston.com/multimedia/graphics/projectFiles/2014/special/social/twitter_icon.png'>
		<a class='facebook' href=''>
			<img src='http://cache.boston.com/multimedia/graphics/projectFiles/2014/special/social/facebook_icon.png'>
		</a>
		<a class='comments' href=''>
			<img src='http://cache.boston.com/multimedia/graphics/projectFiles/2014/special/social/comments_icon.png'>
		</a>
	</div>
	<div class='moreStories'>
		<p>Explore the Game Changers</p>
		<div class='featured'>
		</div>
		<div class='categories'>
			<div id='technology' class='category' data-category='technology'>
				<a href='#' class='label'>Technology</a>
				<div class='stories hide'></div>
			</div>
			<div id='medicine' class='category' data-category='medicine'>
				<a href='#' class='label'>Medicine &amp; Medical</a>
				<div class='stories hide'>
				</div>
			</div>
			<div id='design' class='category' data-category='design'>
				<a href='#' class='label'>Design &amp; Transportation</a>
				<div class='stories hide'></div>
			</div>
			<div id='finance' class='category' data-category='finance'>
				<a href='#' class='label'>Finance &amp; Nonprofits</a>
				<div class='stories hide'></div>
			</div>
			<div id='beta' class='category' data-category='beta'>
				<a href='#' class='label'>Beta Boston</a>
				<div class='stories hide'></div>
			</div>
		</div>
	</div>
</div>
<script>window.sheet_data=[{category:"medicine",title:"PARTNERS HEALTHCARE: Mapping out pathways to a healthier future",slug:"15genome(2).xml",url:"http://www.bostonglobe.com/business/2014/06/14/partners-lab-maps-out-human-genomes-for-patients/PlvpSUcTfNFZF4GgouIZFN/story.html",img:"genome.jpg"},{category:"medicine",title:"PILLPACK: Family pharmacy comes to you",slug:"15pillpack(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/pillpack-reimagines-pharmacy-for-digital-age/XDWKwKq1P8Oktj2fY2SZKL/story.html",img:"pillpack.jpg"},{category:"medicine",title:"CHILDREN’S HOSPITAL: Transplants making children whole",slug:"15childrens(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/children-hospital-creates-world-first-hand-transplant-program-for-young-patients/7ZC3upjbrDMZYfd2diW3ZM/story.html",img:"childrens.jpg"},{category:"medicine",title:"BIOGEN IDEC: Breakthrough MS drug transforms firm",slug:"15biogen.xml",url:"http://www.bostonglobe.com/business/2014/06/14/multiple-sclerosis-pill-tecfidera-became-unexpected-hit-for-biogen-idec/RkGPrsCN5FZk3TNhSR8AzO/story.html",img:"biogen.jpg"},{category:"medicine",title:"IMMUNOGEN: Breast cancer therapy took time",slug:"15immunogen.xml",url:"http://www.bostonglobe.com/business/2014/06/14/immunogen-innovative-payload-platform-powers-potent-kadcyla-breast-cancer-therapy/bB4AyqiGL5ZSaYHw9EIUsK/story.html",img:"immunogen.jpg"},{category:"medicine",title:"NANOBIOSYM: Medical lab in the palm of your hand",slug:"15nanobiosym(2).xml",url:"http://www.bostonglobe.com/business/2014/06/14/putting-medical-lab-laptop/RIMTM41g69zWI3zirPZkqM/story.html",img:"nanobiosym.jpg"},{category:"technology",title:"DRAGON INNOVATION: Site helps fund new consumer electronics",slug:"15dragon(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/dragon-innovation-crowdfunding-site-helps-fund-new-consumer-electronics/e5jIw6W7fJZ2Iws5SsnqgJ/story.html",img:"dragon.jpg"},{category:"technology",title:"BiOM: Bionic ankle gives amputees natural movement",slug:"15biom(2).xml",url:"http://www.bostonglobe.com/business/2014/06/14/biom-bionic-ankle-gives-amputees-natural-movement/nfEuNYOUghcl9ChjuzF5BN/story.html",img:"biom.jpg"},{category:"technology",title:"GOOGLE GLASS: Beth Israel ER gets a little easier",slug:"15googleglass.xml",url:"http://www.bostonglobe.com/business/2014/06/14/google-glass-moves-into-hospital-beth-israel-deaconess/VQNGKK9842vbRIzlM2201J/story.html",img:"googleglass.jpg"},{category:"technology",title:"ALDEBARAN ROBOTICS: NAO robot connects with autistic children",slug:"15aldebaran.xml",url:"http://www.bostonglobe.com/business/2014/06/14/nao-from-aldebaran-robotics-connects-with-autistic-children/l0FpLVqBk4wPsK0q21kxDI/story.html",img:"aldebaran.jpg"},{category:"technology",title:"AEREO: Giving viewers a new way to watch TV",slug:"15aereo(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/aereo-gives-viewers-new-way-watch-television/hCTaaREqdLKxzyblrKUw9L/story.html",img:"aereo.jpg"},{category:"technology",title:"REEBOK AND MC10: Two companies tackle head injuries",slug:"15mc10(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/reebok-develop-device-monitor-athletes-for-head-injuries/IePe0ZTLXg71u2KN4Te7MK/story.html",img:"mc10.jpg"},{category:"technology",title:"BRIDJ: A data-driven bus line for the 21st century",slug:"15bridj(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/data-driven-bus-for-century/5sontSfgEvrulgUhi0IvuO/story.html",img:"bridj.jpg"},{category:"technology",title:"PATRIOTS: Giving fans the comforts of home, at Gillette",slug:"15patsapp.xml",url:"http://www.bostonglobe.com/business/2014/06/14/patriots-stadium-app-offers-fans-all-comforts-home/ZMqiGlpAfVl0gy5Aj4oAmN/story.html",img:"patsapp.jpg"},{category:"technology",title:"PANORAMA: Reading, writing, and feedback",slug:"15panorama(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/panorama-helps-schools-analyze-data-improve-education/v3qYDaz7qkGKS5pMzJ4aEO/story.html",img:"panorama.jpg"},{category:"technology",title:"NEW BALANCE: Creating shoes designed for the way you run",slug:"15newbalance(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/new-balance-sprints-ahead-shoe-manufacturing/LV0rKjDoZh5GRKGXdvx3tO/story.html",img:"newbalance.jpg"},{category:"technology",title:"iROBOT: Developing a new breed of telepresence robot",slug:"15irobot(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/irobot-develops-new-breed-telepresence-robot/NmIJqNUvNxQx2VNs9ouKbP/story.html",img:"irobot.jpg"},{category:"technology",title:"SMART SUBS: Local firms coming to the rescue at sea",slug:"15submarines(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/marine-robots-probing-ocean-depths/lOqNzdHnttjxWea3pbkMLI/story.html",img:"submarines.jpg"},{category:"technology",title:"ARTSBOSTON: Aiding nonprofits in the art of data mining",slug:"15artsboston(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/artsboston-aids-nonprofits-art-data-mining/9Uf74xOMvjXpuNF6huXh1I/story.html",img:"artsboston.jpg"},{category:"technology",title:"SUPERPEDESTRIAN: Wheel gives bikers a boost",slug:"15superpedestrian.xml",url:"http://www.bostonglobe.com/business/2014/06/14/superpedestrian-copenhagen-wheel-gives-bikers-boost/jrD2lZ6ahOqcQz6LBeyhhK/story.html",img:"superpedestrian.jpg"},{category:"technology",title:"BORREGO SOLAR: A solar power boom in Mass.",slug:"15solar(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/solar-power-boom-doubles-massachusetts-capacity/16uOpY41aZrzTcMcb09odL/story.html",img:"solar.jpg"},{category:"technology",title:"FREIGHT FARMS: Farm to table, from your porch",slug:"15freightfarm.xml",url:"http://www.bostonglobe.com/business/2014/06/14/freight-farms-grows-crops-without-fields/zjB1xmnVTu6AxQGIxrnyqO/story.html",img:"freightfarm.jpg"},{category:"design",title:"MASSPORT: Connecting Logan to the broader world",slug:"15logannewroutes(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/logan-expands-its-route-network-boost-trade-tourism/xcgu94LIsRv3hD59P3yv9I/story.html",img:"logannewroutes.jpg"},{category:"design",title:"HELMETHUB: Company uses its head to help you protect yours",slug:"15helmethub.xml",url:"http://www.bostonglobe.com/business/2014/06/14/helmethub-kiosks-add-safety-boston-bike-rentals/vLGtNuMOUC4ZMpYxOoWHsN/story.html",img:"helmethub.jpg"},{category:"design",title:"WAYFAIR: Everything on one site, including the kitchen sink",slug:"15wayfair(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/wayfair-booms-leading-online-retailer-home-furnishings/ZYq13aG6z8MffGePatyOCI/story.html",img:"wayfair.jpg"},{category:"design",title:"EMERSON: College makes a bold move in Hollywood",slug:"15emerson(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/emerson-college-makes-bold-move-hollywood/RmNuLlWiuhx8DULazEjD0K/story.html",img:"emerson.jpg"},{category:"design",title:"ADD: Making a new footprint for a changing city",slug:"15add(2).xml",url:"http://www.bostonglobe.com/business/2014/06/14/add-inc-architects-make-big-impact-thinking-small/rnZpGadVdCzMamFUg3cPXJ/story.html",img:"add.jpg"},{category:"design",title:"URBANICA: Offering housing that gives back",slug:"15urbanica(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/urbanica-builds-boston-first-energy-positive-homes/PZlzyv1WPDlYcePDQgddOO/story.html",img:"urbanica.jpg"},{category:"finance",title:"THIRD ROCK VENTURES: A key engine in biotech startups",slug:"15thirdrock.xml",url:"http://www.bostonglobe.com/business/2014/06/14/third-rock-ventures-has-emerged-key-boston-area-engine-for-forming-biotech-startups/2dfwadT0WXlomO5AjeO0cN/story.html",img:"thirdrock.jpg"},{category:"finance",title:"BOSTON'S FED: A bank that's changing local communities",slug:"15communityworks(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/boston-federal-reserve-bank-changing-local-communities/5UodRg7u9oJAXIsl7LcFMM/story.html",img:"communityworks.jpg"},{category:"finance",title:"ONE FUND BOSTON: Setting a new standard for charities",slug:"15onefund(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/one-fund-boston-symbolized-community-response-marathon-bombing-tragedy/vrC9KOM0O5S6TBnqXdv2uN/story.html",img:"onefund.jpg"},{category:"finance",title:"LOVIN’ SPOONFULS: Delivering food where it's needed",slug:"15lovinspoonfuls(2).xml",url:"http://www.bostonglobe.com/business/2014/06/14/lovin-spoonfuls-delivers-food-where-its-needed/XFFHDSakesq6jhRgBLWJJM/story.html",img:"lovinspoonfuls.jpg"},{category:"letter",title:"LETTER: Recognizing Mass. leaders making a difference",slug:"15letter(1).xml",url:"http://www.bostonglobe.com/business/2014/06/14/game-changers-recognizes-massachusetts-leaders-that-made-difference/MOW6AGZbqKsKLB0x5n08RN/story.html",img:"letter.jpg"},{category:"beta",title:"TELECOM WORLD: It’s all about better, faster, anywhere",slug:"",url:"http://betaboston.com/news/2014/06/13/in-the-telecom-world-its-all-about-more-better-faster-and-anywhere/",img:"telecomm.jpg"},{category:"beta",title:"BIG BOYS: Facebook, Google, Twitter, Apple, and Amazon busy in Boston",slug:"",url:"http://betaboston.com/news/2014/06/13/what-are-facebook-google-twitter-apple-and-amazon-doing-in-boston/",img:"social.jpg"},{category:"beta",title:"INCUBATORS AND ACCELERATORS: Where big ideas are hatched",slug:"",url:"http://betaboston.com/news/2014/06/13/where-big-ideas-are-hatched-incubators-and-accelerators/",img:"bigideas.jpg"},{category:"beta",title:"VENTURE CAPITALISTS: 5 from the Boston area are hunting for the next big idea",slug:"",url:"http://betaboston.com/news/2014/06/13/5-boston-area-venture-capitalists-hunting-for-the-next-big-idea/",img:"vchunting.jpg"},{category:"beta",title:"LABS: 6 college startup programs beyond Harvard, MIT",slug:"",url:"http://betaboston.com/news/2014/06/13/6-college-startup-programs-beyond-harvard-and-mit-college-labs-beyond-mit-and-harvard/",img:"sixstartups.jpg"}],globe.specialGraphic=function(){function e(){_navOff=2*$(".article-nav").height(),l(),i(),r(),t(),c(),g()}function t(){for(var e=0;e<sheet_data.length;e++){var t=sheet_data[e],l=$("#"+t.category).find(".stories"),i='<div class="story">';i+='<a href="'+t.url+'">',i+='<img src="'+m+t.img+'">',i+='<span class="storyTitle">'+t.title+"</span>",i+="</a></div>",l.append(i)}$(".label").on("click",function(e){e.preventDefault();var t=$(this).parent().attr("data-category");return n(t),!1}),$(".categoryNav li a").on("click",function(e){e.preventDefault();var t=$(this).attr("data-category"),o=$(this).text();return a(t,o),s(),!1}),$(".categoryButton").on("click",function(e){return e.preventDefault(),o(),s(),!1}),$("body").on("click",function(){$(".categoryNav ul").hasClass("hide")||s(),o()}),$(".close").on("click",function(e){return e.preventDefault(),o(),!1})}function o(){$(".upTopCategory").addClass("hide"),$(".categoryContent").empty()}function s(){$(".categoryNav ul").toggleClass("hide"),$(".plus").text($(".categoryNav ul").hasClass("hide")?"+":"-")}function a(e,t){var o="#"+e+" .stories";$(".categoryContent").empty();var s=$(o).clone();$(".categoryContent").append(s),$(".categoryLabel").text(t),$(".upTopCategory").removeClass("hide")}function n(e){var t="#"+e;$(t).find(".stories").toggleClass("hide"),$(t).find(".label").toggleClass("hide")}function l(){var e=$(".header .main-hed").text(),t=$(".byline .author").html();$(".articleInfo .newHeadline").text(e),$(".articleInfo .newByline").html(t),$(".articleInfo .newByline a").append(" | Globe Staff");var o=$(".lead-figure").html();$(".articleInfo .newLeadImage").html(o)}function i(){var e=$("nav.utils ul li").last().html(),t=$(e);t.removeClass("top"),$(".globe-account").append(t)}function r(){var e=$(".article-body p").first();1===e.text().length&&e.remove()}function g(){var e=$("ul.article-cats li").eq(1).find("a").attr("href");$(".social .comments").attr("href",e)}function c(){var e=window.location.href,t="#GlobeGameChangers: "+$(".newHeadline").text(),o=encodeURIComponent(t+" via @BostonGlobe "),s="https://twitter.com/intent/tweet?text="+o+"&url="+encodeURI(e),a="https://www.facebook.com/sharer/sharer.php?u="+encodeURI(e)+"&t="+o;$(".twitter").attr("href",s),$(".facebook").attr("href",a)}var m="http://cache.boston.com/multimedia/graphics/projectFiles/2014/06/gamechangers/stories/";e()},globe.onDefine('window.jQuery && $("#gf-special-graphic").length',function(){globe.specialGraphic()});</script>

</div>
</p><!----><p></p><i>Robert Weisman can be reached at <a class="a" href="mailto:robert.weisman@globe.com">robert.weisman@globe.com</a>. Follow him on Twitter <a class="a" href="http://twitter.com/GlobeRobW">@GlobeRobW</a>.</i><!-- inside story_update.jpt -->
</div><!-- end article-text -->
					<!-- Story tools -->
						<!-- for comments -->
					<footer class="article-footer" role="contentinfo">
<script>var uuid = '600ef2ac-ec20-11e3-88f3-8609f4775199';</script>
<div id="comments">
	<div id="comments-content" class="ugc-comments comments">
		<div class="loading-message" id="loading-comments">
			Loading comments...
			 </div>
	</div>
</div>
<div id="newcomments"></div>
</footer>
</div><!-- ends article-body -->
				<!-- place for ads and trending -->
				<nav id="section-nav" class="section-nav trending-nav" data-sectionname="/business">
     <h3>Top 10 Trending Articles</h3>
      <nav>
        <ul class="bg-tabs-sidebar bg-33-33-33">
          <li><a class="here js-show-tab" href="#most-viewed">Most Viewed</a></li>
          <li><a class="js-show-tab" href="#most-commented">Most Commented</a></li>
          <li><a class="js-show-tab" href="#most-shared">Most Shared</a></li>
        </ul>
      </nav>

      </nav>

  <div id="ad_outofpage1" class="ad outofpage1"></div>
</article>
		</main>
		<!-- Page footer -->
<div class="subscription-banner">
	<a class="subscription-banner__link" href="http://subscribe.bostonglobe.com/B0565?p1=BGFooter_DigitalSubscription_Banner">
		<span class="subscription-banner__title">Real journalists. Real journalism. </span>
		<span class="subscription-banner__cta" >Subscribe to The Boston Globe today.</span>
	</a>
</div>
<footer class="site-footer" role="contentinfo">
	<div class="site-footer__content">
		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">My Account</h3></li>
			<li class="site-footer__list-item"><a href="https://manage.bostonglobe.com/cs/mc/login.aspx?p1=BGFooter" class="site-footer__link">Manage my Account</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobe.com/bgcs" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - Download Customer Service App');">Mobile Customer Service</a></li>
			<li class="site-footer__list-item"><a href="/newsletters?p1=BGFooter_Newsletters" class="site-footer__link">Sign Up For Newsletters</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">Contact</h3></li>
			<li class="site-footer__list-item"><a href="https://bostonglobe.custhelp.com/app/home?p1=BGFooter" class="site-footer__link">Help</a></li>
			<li class="site-footer__list-item"><a href="https://bostonglobe.custhelp.com/app/answers/list?p1=BGFooter" class="site-footer__link">FAQs</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/stafflist?p1=BGFooter" class="site-footer__link">Globe newsroom</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobemedia.com/" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - BGM Home Page');">Advertise</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">Social</h3></li>
			<li class="site-footer__list-item"><a href="https://www.facebook.com/globe" class="site-footer__link">Facebook</a></li>
			<li class="site-footer__list-item"><a href="https://twitter.com/#!/BostonGlobe" class="site-footer__link">Twitter</a></li>
			<li class="site-footer__list-item"><a href="https://plus.google.com/108227564341535363126/about" class="site-footer__link">Google+</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">More</h3></li>
		    <li class="site-footer__list-item"><a href="http://epaper.bostonglobe.com/launch.aspx?pbid=2c60291d-c20c-4780-9829-b3d9a12687cf" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - EPaper launch');">ePaper</a></li>
			<li class="site-footer__list-item"><a href="http://nieonline.com/bostonglobe/" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - News In Education');">News in Education</a></li>
			<li class="site-footer__list-item"><a href="https://secure.pqarchiver.com/boston-sub/no_default.html?ss=1&amp;url=%2Fboston-sub%2Fadvancedsearch.html" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - Public Archives');">Archives</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/privacy?p1=BGFooter" class="site-footer__link">Privacy policy</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/terms-service?p1=BGFooter" class="site-footer__link">Terms of service</a></li>
			<li class="site-footer__list-item"><a href="/termsofpurchase?p1=BGFooter" class="site-footer__link">Terms of purchase</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobemedia.com/careers" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - BGM Careers');">Work at Boston Globe Media</a></li>
		</ul>
		<p class="site-footer__copyright">&copy; 2017 Boston Globe Media Partners, LLC</p>
	</div>
</footer>

<script type="text/javascript" src="//tags.mediaforge.com/js/4600"></script>

<script type="text/javascript">
	var google_conversion_id = 1071256246;
	var google_custom_params = window.google_tag_params;
	var google_remarketing_only = true;
</script>
<script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js" ></script>
<noscript>
	<div style="display:inline;">
		<img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/1071256246/?value=0&amp;guid=ON&amp;script=0"/>
	</div>
</noscript><div class="ad ad-slot-c" id="EXTRA"></div><!-- Tracking -->
<!-- stubView3 =  -->
<!-- sPageNameExt: ImmunoGen\u2019s breast cancer therapy took time -->
		

		
			
			
				
			
		
		
		

		
		
			
				
			
		

		
			
		

	
	
	
	
	
	
	








	
		
	
	




<!-- sectionpath /business -->



<!-- pageTitle:  -->

<!-- Determine sprop_3 -->




	
		
	
	
		
		
		<!-- authors: Robert Weisman -->
	

<script>
	var sPageName = (typeof sPageNameOverride != 'undefined') ? sPageNameOverride : 'Business | ImmunoGen\u2019s breast cancer therapy took time';
	//if (typeof sPageNameOverride != 'undefined') {
	//	sPageName = sPageNameOverride;
	//}
	var sChannel = (typeof sChannelOverride != 'undefined') ? sChannelOverride : 'Business';
	//var sChannel  = 'Business';
	var sProp1    = 'Business';
	var sProp3    = 'Robert Weisman';
	var sProp4    = 'Standard';
	//var sProp6    = 'Article Page | Globe';
	var sProp6    = (typeof sProp6Val != 'undefined') ? sProp6Val : 'Article Page | Globe';
	var sProp8	  = '06/15/2014 04:00:00 AM';
	var sProp16    = 'none';
	var sProp67	  = '600ef2ac-ec20-11e3-88f3-8609f4775199';
	var sProp68	  = 'ImmunoGen\u2019s breast cancer therapy took time';
	var sProp6a = sProp6;
	var sProp1a = sProp1;
	var sPageNamea = sPageName;
	var taxonomies = 'Business/Innovation';
	var sChannela = sChannel;
	  if ( methode.showPaywall ) {
	    sChannel  = 'Member Center';
	    sProp1    = 'Member Center | BGC Registration';
	    if ( $(window).width() <= 768 ) {
	      // assume mobile
	      sPageName = 'Member Center | BGC Registration | Fullpage Paywall Challenge';
	      sProp6    = 'BGC Registration Page - Fullpage';
	    } else {
	      // assume desktop
	      sPageName = 'Member Center | BGC Registration | Modal Paywall Challenge';
	      sProp6    = 'BGC Registration Page - Modal';
	    }
	  }
	globe.extend(globe.analytics.omniture, {
	  'pageType' : '',
	  'pageName' : sPageName,
	  'channel'  : sChannel,
	  'prop1'    : sProp1,
	  'prop3'    : sProp3,
	  'prop4'    : sProp4,
	  'prop6'    : sProp6,
	  'prop8'    : sProp8,
	  'prop16'    : sProp16,
	  
		'prop35' : 'logged out',
		'eVar20' : 'logged out',
   		'prop42' : 'Metered',
   		'eVar42' : 'Metered',

	  'eVar16'   : 'none',
	  'eVar41'   : 'BostonGlobe.com',
	  'eVar41'   : 'BostonGlobe.com',
	  'eVar67'   : sProp67,
	  'prop67'    : sProp67,
	  'prop68'    : sProp68,
	  'list2'	 : taxonomies,
	  'WT omnituretracking.tag' : 'story'
	});
</script>

<noscript>
	<img src="http://newyorktimes.112.2o7.net/b/ss/nytbostonglobecom/1/H.23.3--NS/0?pageName=News%20%7C%20BGC%20Homepage&amp;ch=News&amp;c1=News%20%7C%20BGC%20Homepage&amp;c6=BGC%20Homepage&amp;c41=BostonGlobe.com&amp;v41=BostonGlobe.com" height="1" width="1" border="0" alt="" />
</noscript>


</div>
<script src="/js/dist/globe-sticky-tools.js,dist/globe-sticky-masthead.js,dist/globe-topic-nav.js,dist/globe-analytics.js,dist/lib/modernizr.custom.min.js?v=18279I1728"></script>
<link rel="stylesheet" type="text/css" href="//meter.bostonglobe.com/css/style.css">
<script src="//meter.bostonglobe.com/js/meter.js"></script>
<script src="/js/dist/globe-header.js,dist/globe-blueconic.js,dist/chartbeat.js,dist/continue-reading.js,dist/globe-subscription-banner.js,dist/globe-adcatalog.js,dist/globe-adinclude.js,dist/globe-comments.js,dist/globe-masthead.js?v=18279I1728"></script>
<script type="text/javascript">
	(function() {
		if (typeof window.meterObject !== 'undefined') {
			
			// Change the meter base URL (this allows all campaign links to be relative) for this particular environment.
			window.meterObject.updateBaseURL('https://www.bostonglobe.com');
			
			window.meterObject.executeMeter({
				loid:'3.2.4154197919',
				uuid:'600ef2ac-ec20-11e3-88f3-8609f4775199',
				
				exemptFromMeter: false
			});
			
		}

	})();
</script>
</body>
</html>

